Also known as: Body Protection Compound-157 · PL 14736
A synthetic pentadecapeptide studied in preclinical models for connective-tissue and gut research.
§ In brief
A synthetic pentadecapeptide studied in preclinical models for connective-tissue and gut research.
BPC-157 is catalogued here as a reference compound for tissue-repair and regenerative research. The entry covers its chemical identity and the public databases that describe it; it is not a usage guide.
BPC-157 appears in the tissue-repair and regenerative literature, primarily in in-vitro and preclinical (animal) models. This page indexes 4 primary papers on BPC-157, each tagged with its study type below. Peptidoteca summarizes the proposed mechanism class and the primary sources rather than human outcomes; for the wider library, see the research library.
No. BPC-157 is supplied for laboratory (in-vitro) research use only. It is not approved by the FDA or any comparable regulator for human or veterinary use, and nothing on this page constitutes medical advice, dosing guidance or a treatment recommendation.
Most available evidence for BPC-157 is preclinical — in-vitro and animal models — and findings in those models do not establish efficacy or safety in humans. Human clinical data is limited or absent, and BPC-157 is not an approved drug. Treat the literature as mechanistic research, not clinical guidance.
§ Primary literature
For in-vitro research only. Not medical, clinical or dosing advice.